332 research outputs found

    Wind mapping in Venus' upper mesosphere with the IRAM-Plateau de Bure interferometer

    Full text link
    The dynamics of the upper mesosphere of Venus (~85-115 km) have been characterized as a combination of a retrograde superrotating zonal wind (RSZ) with a subsolar-to-antisolar flow (SSAS). Numerous mm-wave single-dish observations have been obtained and could directly measure mesospheric line-of-sight winds by mapping Doppler-shifts on CO rotational lines, but their limited spatial resolution makes their interpretation difficult. By using interferometric facilities, one can obtain better resolution on Doppler-shifts maps, allowing in particular to put firmer constraints on the respective contributions of the SSAS and RSZ circulations to the global mesospheric wind field. We report on interferometric observations of the CO(1-0) line obtained with the IRAM-Plateau de Bure interferometer in November 2007 and June 2009, that could map the upper mesosphere dynamics on the morning hemisphere with a very good spatial resolution (3.5-5.5"). All the obtained measurements show, with a remarkably good temporal stability, that the wind globally flows in the (sky) East-West direction, corresponding in the observed geometry either to an unexpected prograde zonal wind or a SSAS flow. A very localized inversion of the wind direction, that could correspond to a RSZ wind, is also repeatedly detected in the night hemisphere. The presence of significant meridional winds is not evidenced. Using models with different combinations of zonal and SSAS winds, we find that the data is best reproduced by a dominant SSAS flow with a maximal velocity at the terminator of ~200 m/s, displaying large diurnal and latitudinal asymmetries, combined with an equatorial RSZ wind of 70-100 m/s, overall indicating a wind-field structure consistent with but much more complex than the usual representation of the mesospheric dynamics.Comment: Accepted for publication in A&

    Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure

    Get PDF
    The methotrexate (MTX) rescue agent carboxypeptidase G2 (CPDG2) rapidly hydrolyses MTX to the inactive metabolite DAMPA (4-[[2,4-diamino-6-(pteridinyl)methyl]-methylamino]-benzoic acid) and glutamate in patients with MTX-induced renal failure and delayed MTX excretion. DAMPA is thought to be an inactive metabolite of MTX because it is not an effective inhibitor of the MTX target enzyme dihydrofolate reductase. DAMPA is eliminated more rapidly than MTX in these patients, which suggests a nonrenal route of elimination. In a phase II study (May 1997–March 2002), CPDG2 was administered intravenously to 82 patients at a median dose of 50 U kg−1 (range 33–60 U kg−1). Eligible patients for this study had serum MTX concentrations of >10 μM at 36 h or >5 μM at 42 h after start of MTX infusion and documented renal failure (serum creatinine ⩾1.5 times the upper limit of normal). Immediately before CPDG2 administration, a median MTX serum level of 11.93 μM (range 0.52–901 μM) was documented. Carboxypeptidase G2 was given at a median of 52 h (range 25–178 h) following the start of an MTX infusion of 1–12 g m−2 4–36 h−1 and resulted in a rapid 97% (range 73–99%) reduction of the MTX serum level. Toxicity related to CPDG2 was not observed. Toxicity related to MTX was documented in about half the patients; four patients died despite CPDG2 administration due to severe myelosuppression and septic complications. In conclusion, administration of CPDG2 is a well-tolerated, safe and a very effective way of MTX elimination in delayed excretion due to renal failure

    World-leading science with SPIRou - the nIR spectropolarimeter / high-precision velocimeter for CFHT

    Full text link
    SPIRou is a near-infrared (nIR) spectropolarimeter / velocimeter proposed as a new-generation instrument for CFHT. SPIRou aims in particular at becoming world-leader on two forefront science topics, (i) the quest for habitable Earth-like planets around very- low-mass stars, and (ii) the study of low-mass star and planet formation in the presence of magnetic fields. In addition to these two main goals, SPIRou will be able to tackle many key programs, from weather patterns on brown dwarf to solar-system planet atmospheres, to dynamo processes in fully-convective bodies and planet habitability. The science programs that SPIRou proposes to tackle are forefront (identified as first priorities by most research agencies worldwide), ambitious (competitive and complementary with science programs carried out on much larger facilities, such as ALMA and JWST) and timely (ideally phased with complementary space missions like TESS and CHEOPS). SPIRou is designed to carry out its science mission with maximum efficiency and optimum precision. More specifically, SPIRou will be able to cover a very wide single-shot nIR spectral domain (0.98-2.35 \mu m) at a resolving power of 73.5K, providing unpolarized and polarized spectra of low-mass stars with a ~15% average throughput and a radial velocity (RV) precision of 1 m/s.Comment: 12 pages, 5 figures, conference proceedings of the French Society of Astronomy and Astrophysics meeting 201

    Probing Rock Type, Fe Redox State, and Transition Metal Contents with Six-Window VNIR Spectroscopy Under Venus Conditions

    Get PDF
    VEM-window data are shown to distinguish among key rock types on Venus, and evaluate redox state and transition metal contents of Venus surface rocks

    Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1.

    Get PDF
    Neurofibromatosis Type 1 (NF1) is a genetic disease caused by mutations in Neurofibromin 1 (NF1). NF1 patients present with a variety of clinical manifestations and are predisposed to cancer development. Many NF1 animal models have been developed, yet none display the spectrum of disease seen in patients and the translational impact of these models has been limited. We describe a minipig model that exhibits clinical hallmarks of NF1, including café au lait macules, neurofibromas, and optic pathway glioma. Spontaneous loss of heterozygosity is observed in this model, a phenomenon also described in NF1 patients. Oral administration of a mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor suppresses Ras signaling. To our knowledge, this model provides an unprecedented opportunity to study the complex biology and natural history of NF1 and could prove indispensable for development of imaging methods, biomarkers, and evaluation of safety and efficacy of NF1-targeted therapies

    Study of the plutino object (208996) 2003 AZ84 from stellar occultations: size, shape and topographic features

    Full text link
    We present results derived from four stellar occultations by the plutino object (208996) 2003~AZ84_{84}, detected at January 8, 2011 (single-chord event), February 3, 2012 (multi-chord), December 2, 2013 (single-chord) and November 15, 2014 (multi-chord). Our observations rule out an oblate spheroid solution for 2003~AZ84_{84}'s shape. Instead, assuming hydrostatic equilibrium, we find that a Jacobi triaxial solution with semi axes (470±20)×(383±10)×(245±8)(470 \pm 20) \times (383 \pm 10) \times (245 \pm 8)~km % axis ratios b/a=0.82±0.05b/a= 0.82 \pm 0.05 and c/a=0.52±0.02c/a= 0.52 \pm 0.02, can better account for all our occultation observations. Combining these dimensions with the rotation period of the body (6.75~h) and the amplitude of its rotation light curve, we derive a density ρ=0.87±0.01\rho=0.87 \pm 0.01~g~cm3^{-3} a geometric albedo pV=0.097±0.009p_V= 0.097 \pm 0.009. A grazing chord observed during the 2014 occultation reveals a topographic feature along 2003~AZ84_{84}'s limb, that can be interpreted as an abrupt chasm of width 23\sim 23~km and depth >8> 8~km or a smooth depression of width 80\sim 80~km and depth 13\sim 13~km (or an intermediate feature between those two extremes)

    The stellar occultation by Makemake on 2011 April 23

    Full text link
    We have taken advantage of a stellar occultation by the dwarf planet Makemake on 2011 April 23, to determine several of its main physical properties. We present results from a multisite campaign with 8 positive occultation detections from 5 different sites, including data from the 8-m VLT and 3.5-m NTT telescopes in Chile, which have very high temporal resolution. Because the star was significantly fainter than Makemake (setting a record in the magnitude of a star whose occultation has been detected), the occultation resulted in a drop of just ~0.3 mag in the lightcurves. From the lightcurves we have been able to determine the size and shape of the body, its geometric albedo and constraints on its atmosphere
    corecore